Publications

5600 Results

Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial

Authors
F von Rundstedt;DA Mata;S Groshen;J Stein;D Skinner;WM Stadler;RJ Cote;ON Kryvenko;G Godoy;S Lerner
Journal / Conference
British Journal of Urology International Jul 116(1):44-49
Year
2015
Research Committee(s)
Genitourinary
PMID
PMID25413313
PMC
PMC4524781
Study Number(s)
4B951

Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial

Authors
S Lui;J-A Chapman;MJ Burnell;MN Levine;KI Pritchard;TJ Whelan;RS Rugo;K Albain;EA Perez;S Virk;G Barry;D Gao;P O'Brien;L Shepherd;TO Nielsen;KA Gelmon
Journal / Conference
Breast Cancer Research and Treatment Jan;149(2):439-448, 2015
Year
2015
Research Committee(s)
Breast
PMID
PMID25552364

Innovative Clinical Trials: The LUNG-MAP Study

Authors
CE Steuer;V Papadimitrakopoulou;R Herbst;M Redman;F Hirsch;P Mack;SS Ramalingam;DR Gandara
Journal / Conference
Clinical Pharmacology and Therapeutics, May;97(5):488-491
Year
2015
Research Committee(s)
Lung
PMID
PMID25676724
PMC
n/a - review
Study Number(s)
S1400

Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32

Authors
PJ Goodwin;W Parulear;K Gelmon;LE Shepherd;JA Ligibel;DL Hershman;P Rastogi;I Mayer;T Hobday;J Lemieux;AM Thompson;K Pritchard;SD Mukherjee;HI Chalchal;CD Oja;K Tonkin;V Bernstein;B Chen;V Stambolic
Journal / Conference
Journal of the National Cancer Institute 2015 Mar 4;107(3). pii: djv006. Print 2015 Mar.
Year
2015
Research Committee(s)
Breast
PMID
PMID25740979

Treatment-associated musculoskeletal and vasomotor symptoms and relapse-free survival in the NCIC CTG MA.27 adjuvant breast cancer aromatase inhibitor trial

Authors
V Stearns;JW Chapman;CX Ma;MJ Ellis;JN Ingle;K Pritchard;GT Budd;M Rabaglio;G Sledge;A Le Maitre;J Kundapur;P Liedke;LE Shepherd;P Goss
Journal / Conference
Journal of Clinical Oncology Jan 20;33(3):265-271
Year
2015
Research Committee(s)
Breast
PMID
PMID5512454
PMC
PMC4289722

Baseline subjective memory complaints associate with increased risk of incident dementia: The PREADVISE Trial

Authors
EL Abner;RJ Kryscio;A Caban-Holt;FA Schmitt
Journal / Conference
Journal of Prevention of Alzheimers Disease 2(1):11-16
Year
2015
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID26180776
PMC
PMC4500536
Study Number(s)
S0000A

Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population [Collaborators: K Guthrie, C Blanke] (https://www.ncbi.nlm.nih.gov/pubmed/25697217)

Authors
LA Renfro;A Grothey;D Kerr;DG Haller;T Andre;E Van Cutsem;L Saltz;R Labianca;CL Loprinzi;SR Alberts;H Schmoll;C Twelves;G Yothers;DJ Sargent
Journal / Conference
Annals of Oncology May;26(5):950-958; 2015
Year
2015
Research Committee(s)
Gastrointestinal
PMID
PMID25697217
PMC
PMC4405281
Study Number(s)
SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415)

Chemotherapy + radiation and chemotherapy alone in limited stage diffuse large B-cell lymphoma (DLBCL): Final and long-term analysis of SWOG Study S8736 (http://onlinelibrary.wiley.com/doi/10.1002/hon.2227/epdf)

Authors
DM Stephens;M Leblanc;H Li;TP Miller;S Puvvada;D Persky;JW Friedberg;S Smith
Journal / Conference
Hematological Oncology 33: (Suppl S1, abst. 128) p.170; International Conference on Malignant Lymphoma (June 17-20, 2015, Lugano, Switzerland), oral;
Year
2015
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8736 (INT-0093)

The globalization of cooperative groups

Authors
M Valdivieso;B Corn;J Dancey;DL Wickerham;LE Horvath;EA Perez;A Urton;WM Cronin;E Field;E Lackey;CD Blanke
Journal / Conference
Seminars in Oncology, Oct;42(5):693-712
Year
2015
Research Committee(s)
Cancer Care Delivery
PMID
PMID26433551
PMC
PMC4592942

The National Clinical Trials Network: Conducting successful clinical trials of new therapies for rare cancers

Authors
AF Schott;JJ Welch;CF Verschraegen;R Kurzrock
Journal / Conference
Seminars in Oncology, Oct;42(5):731-739
Year
2015
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID26433554
PMC
PMC4673983